Literature DB >> 12525676

AIDS-related malignancies.

David T Scadden1.   

Abstract

Immunodeficiency alters the risk of cancer. Specific types of immune dysfunction are associated with different tumor risks, but most tumors are related to oncogenic viruses. In acquired immunodeficiency due to the human immunodeficiency virus (HIV), HIV itself rarely directly causes cancer; rather, it provides the immunologic background against which other viruses can escape immune control and induce tumors. The most common malignancies are Kaposi's sarcoma and non-Hodgkin's lymphoma. This chapter discusses the pathophysiologic background of these tumors, how they have been affected by the use of anti-HIV medications, and their clinical management.

Entities:  

Mesh:

Year:  2001        PMID: 12525676     DOI: 10.1146/annurev.med.54.101601.152143

Source DB:  PubMed          Journal:  Annu Rev Med        ISSN: 0066-4219            Impact factor:   13.739


  10 in total

1.  Reduction of retrovirus-induced immunosuppression by in vivo modulation of T cells during acute infection.

Authors:  Hong He; Ronald J Messer; Shimon Sakaguchi; Guojun Yang; Shelly J Robertson; Kim J Hasenkrug
Journal:  J Virol       Date:  2004-11       Impact factor: 5.103

2.  Granulocytic sarcoma and HIV.

Authors:  John R Krause; Ibrahim Aburiziq
Journal:  Proc (Bayl Univ Med Cent)       Date:  2011-10

Review 3.  Molecular biology of KSHV in relation to AIDS-associated oncogenesis.

Authors:  Whitney Greene; Kurt Kuhne; Fengchun Ye; Jiguo Chen; Fuchun Zhou; Xiufen Lei; Shou-Jiang Gao
Journal:  Cancer Treat Res       Date:  2007

Review 4.  Management of patients with HIV in the intensive care unit.

Authors:  Henry Masur
Journal:  Proc Am Thorac Soc       Date:  2006

Review 5.  The endocannabinoid system as an emerging target of pharmacotherapy.

Authors:  Pál Pacher; Sándor Bátkai; George Kunos
Journal:  Pharmacol Rev       Date:  2006-09       Impact factor: 25.468

6.  Kaposi's sarcoma-associated herpesvirus-encoded protein kinase and its interaction with K-bZIP.

Authors:  Yoshihiro Izumiya; Chie Izumiya; Albert Van Geelen; Don-Hong Wang; Kit S Lam; Paul A Luciw; Hsing-Jien Kung
Journal:  J Virol       Date:  2006-11-15       Impact factor: 5.103

7.  Differentiation of HIV-associated lymphoma from HIV-associated reactive adenopathy using quantitative FDG PET and symmetry.

Authors:  Joyce C Mhlanga; Daniel Durand; Hua-Ling Tsai; Christine M Durand; Jeffrey P Leal; Hao Wang; Richard Moore; Richard L Wahl
Journal:  Eur J Nucl Med Mol Imaging       Date:  2014-01-28       Impact factor: 9.236

Review 8.  A critical analysis of the tumour immunosurveillance controversy for 3-MCA-induced sarcomas.

Authors:  T H Schreiber; E R Podack
Journal:  Br J Cancer       Date:  2009-08-04       Impact factor: 7.640

9.  Exploitation of Cellular Cytoskeletons and Signaling Pathways for Cell Entry by Kaposi's Sarcoma-Associated Herpesvirus and the Closely Related Rhesus Rhadinovirus.

Authors:  Wei Zhang; Shou-Jiang Gao
Journal:  Pathogens       Date:  2012-10-22

10.  Kaposi's sarcoma manifested as lower gastrointestinal bleeding in a HIV/HBV-co-infected liver cirrhosis patient: A case report.

Authors:  Qi-Hui Zhou; Yong-Zheng Guo; Xia-Hong Dai; Biao Zhu
Journal:  World J Clin Cases       Date:  2019-10-06       Impact factor: 1.337

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.